Bevacizumab plus irinotecan with or without gamma knife radiosurgery after failure of concurrent chemo-radiotherapy for high-grade glioma
暂无分享,去创建一个
H. Seol | Jung-Il Lee | D. Kong | D. Nam | Se-Hoon Lee | H. Jung | J. Choi | Yong-Pyo Lee | Min-Sang Lee
[1] M. Weller,et al. Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma , 2020, JAMA oncology.
[2] Versione,et al. Common Terminology Criteria for Adverse Events , 2020, Definitions.
[3] Jill S Barnholtz-Sloan,et al. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011-2015. , 2018, Neuro-oncology.
[4] M. Shamim,et al. The significance of MGMT methylation in Glioblastoma Multiforme prognosis. , 2018, JPMA. The Journal of the Pakistan Medical Association.
[5] M. Mrugala,et al. Pivotal therapeutic trials for infiltrating gliomas and how they affect clinical practice. , 2017, Neuro-oncology practice.
[6] Martin Klein,et al. Lomustine and Bevacizumab in Progressive Glioblastoma , 2017, The New England journal of medicine.
[7] Inamullah Khan,et al. Prognostic significance of IDH 1 mutation in patients with glioblastoma multiforme. , 2017, JPMA. The Journal of the Pakistan Medical Association.
[8] Erich P Huang,et al. RECIST 1.1-Update and clarification: From the RECIST committee. , 2016, European journal of cancer.
[9] H. Seol,et al. Outcome of salvage treatment for recurrent glioblastoma , 2015, Journal of Clinical Neuroscience.
[10] T. Mesti,et al. Bevacizumab and irinotecan in recurrent malignant glioma, a single institution experience , 2015, Radiology and oncology.
[11] J. Carlson,et al. Clinical Clinical outcomes following salvage Gamma Knife radiosurgery for recurrent glioblastoma , 2014 .
[12] Matthew J. Oborski,et al. Cancer Management and Research Dovepress Malignant Gliomas: Current Perspectives in Diagnosis, Treatment, and Early Response Assessment Using Advanced Quantitative Imaging Methods , 2022 .
[13] K. Aldape,et al. A randomized trial of bevacizumab for newly diagnosed glioblastoma. , 2014, The New England journal of medicine.
[14] Nina Kočevar,et al. Glioma and glioblastoma - how much do we (not) know? , 2013, Molecular and clinical oncology.
[15] W. Curran,et al. RTOG 0211: a phase 1/2 study of radiation therapy with concurrent gefitinib for newly diagnosed glioblastoma patients. , 2013, International journal of radiation oncology, biology, physics.
[16] D. Kondziolka,et al. Salvage gamma knife stereotactic radiosurgery followed by bevacizumab for recurrent glioblastoma multiforme: a case–control study , 2012, Journal of Neuro-Oncology.
[17] A. Kyritsis,et al. An algorithm for chemotherapy treatment of recurrent glioma patients after temozolomide failure in the general oncology setting , 2011, Cancer Chemotherapy and Pharmacology.
[18] Raymond Sawaya,et al. Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] Susan M. Chang,et al. Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] T. Mikkelsen,et al. Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] John A Butman,et al. Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] Lawrence B Marks,et al. The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery. , 2008, Seminars in radiation oncology.
[23] Jung-Il Lee,et al. Efficacy of stereotactic radiosurgery as a salvage treatment for recurrent malignant gliomas , 2008, Cancer.
[24] E. Perez,et al. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer. , 2007, The New England journal of medicine.
[25] John Sampson,et al. Bevacizumab plus irinotecan in recurrent glioblastoma multiforme. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] B. Scheithauer,et al. The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.
[27] Martin J. van den Bent,et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.
[28] J. Berlin,et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. , 2004, The New England journal of medicine.
[29] David M Jablons,et al. Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] Seth M Steinberg,et al. A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer. , 2003, The New England journal of medicine.
[31] P Van Tassel,et al. Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment. , 2000, Radiology.
[32] D. Silbergeld,et al. Isolation and characterization of human malignant glioma cells from histologically normal brain. , 1997, Journal of neurosurgery.
[33] D. Moody,et al. MRI of radiation injury to the brain. , 1986, AJR. American journal of roentgenology.
[34] Kahkashan Perveen,et al. Glioblastoma Multiforme: A Review of its Epidemiology and Pathogenesis through Clinical Presentation and Treatment , 2017, Asian Pacific journal of cancer prevention : APJCP.
[35] J. Barnholtz-Sloan,et al. CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006-2010. , 2013, Neuro-oncology.
[36] M. Prados,et al. Patterns of recurrence of glioblastoma multiforme after external irradiation followed by implant boost. , 1994, International journal of radiation oncology, biology, physics.